ArticleBMC pregnancy and childbirth2025
Induction of labour outcomes in a tertiary hospital: the Ghanaian cervix and misoprostol 25ug (GCAM-25 STUDY)-a cross-sectional study.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInduction of labour is an indispensable obstetric procedure, although associated with some complications. The World Health Organization recommends the use of low dose misoprostol to reduce adverse induction outcomes like uterine hyperstimulation and rupture. With the current availability of 25ug misoprostol tablets in Ghana, this study assesses the effectiveness and safety of 25ug intravaginal misoprostol among women with low risk postdate pregnancies (between 41 weeks and 43 weeks) induced at the premier tertiary healthcare facility in the country.
methodsA cross-sectional study of low risk postdate pregnant women scheduled for induction of labour at Korle- Bu Teaching Hospital between 21st July 2022 and 30th April 2023. The primary outcome was the mode of delivery following induction of labour. The secondary outcomes included: induction to delivery interval, maternal complications, fetal complications and the predictors of successful vaginal delivery.
resultsAmong 168 women analysed, 138/168 participants (82.1%) had vaginal delivery and 30/168 participants (17.9%) had caesarean section. The commonest indication for caesarean section was failure to progress, accounting for 40% of cases. The proportion of postdate women that had vaginal delivery within 24 h of induction was 117/168 (69.6%) with a CI of 62.1-76.5. The mean induction to vaginal delivery time was 17.39 (± 7.31) hours. There were no cases of uterine rupture, hyperstimulation, maternal mortality or still births recorded during the study. Fetal heart rate abnormalities occurred in 8.9% of participants, meconium staining of liquor occurred in twenty-five participants (14.9%). Eleven babies (6.5%) had low APGAR score (< 7) at five minutes and seventeen babies (10.1%) required NICU admission. Parity was the only significant predictor of vaginal delivery. (OR 3.14, 95% CI:1.38-7.13)
conclusionThe 25ug misoprostol induction protocol is effective and safe for the Ghanaian population with low risk postdate pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.